Dispatches from a Pandemic: ‘It was a wise decision to spread the risk’: Johnson & Johnson saga reveals vulnerabilities in COVID-19 vaccine strategy
“It’s still a race between the variants and the vaccine,” said Amesh Adalja, a senior scholar at the John Hopkins Center for Health Security.
